• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β2在人胶质母细胞瘤中的表达:在抵抗免疫排斥中起作用?

Expression of TGF-beta 2 in human glioblastoma: a role in resistance to immune rejection?

作者信息

Fontana A, Bodmer S, Frei K, Malipiero U, Siepl C

机构信息

Department of Internal Medicine, University Hospital, Zürich, Switzerland.

出版信息

Ciba Found Symp. 1991;157:232-8; discussion 238-41. doi: 10.1002/9780470514061.ch15.

DOI:10.1002/9780470514061.ch15
PMID:1649035
Abstract

Glioblastomas are among the most malignant tumours for which no curative treatment exists. A dysfunction of cellular immunity with decreased skin reactivity and lymphocyte blastogenesis has been described in patients with glioblastomas. In culture human glioblastoma cells release a factor termed glioblastoma-derived T cell suppressor factor (G-TsF) which inhibits the antigen-dependent growth of both helper and cytotoxic T cells. Purification and cloning indicated that G-TsF is a novel member of the TGF-beta family with a well-conserved mature sequence but less homology in the precursor segments. The factor was renamed TGF-beta 2. The two glioblastoma cell lines investigated expressed mRNAs for both G-TsF/TGF-beta 2 and TGF-beta 1 but only G-TsF/TGF-beta 2 protein was secreted. Neuroblastoma cells express only the mRNA for TGF-beta 1 but not the protein, nor the mRNA for G-TsF/TGF-beta 2. Recombinant G-TsF/TGF-beta 2 inhibits the generation of virus-specific cytotoxic T cells when injected into mice infected with lymphocytic choriomeningitis virus. Thus G-TsF/TGF-beta 2 might contribute to the impairment of tumour immune surveillance. Some T cell clones may escape the immunosuppressive effects of TGF-beta: ovalbumin-specific T helper cell lines that showed different degrees of susceptibility to TGF-beta contained clones which had lost receptor(s) for TGF-beta.

摘要

胶质母细胞瘤是最恶性的肿瘤之一,目前尚无治愈性治疗方法。已有研究报道,胶质母细胞瘤患者存在细胞免疫功能障碍,表现为皮肤反应性降低和淋巴细胞母细胞生成减少。在培养过程中,人胶质母细胞瘤细胞释放一种称为胶质母细胞瘤衍生的T细胞抑制因子(G-TsF)的因子,该因子可抑制辅助性T细胞和细胞毒性T细胞的抗原依赖性生长。纯化和克隆表明,G-TsF是转化生长因子-β(TGF-β)家族的一个新成员,其成熟序列高度保守,但前体片段的同源性较低。该因子随后被重新命名为TGF-β2。所研究的两种胶质母细胞瘤细胞系均表达G-TsF/TGF-β2和TGF-β1的mRNA,但仅分泌G-TsF/TGF-β2蛋白。神经母细胞瘤细胞仅表达TGF-β1的mRNA,不表达该蛋白,也不表达G-TsF/TGF-β2的mRNA。重组G-TsF/TGF-β2注射到感染淋巴细胞性脉络丛脑膜炎病毒的小鼠体内时,可抑制病毒特异性细胞毒性T细胞的产生。因此,G-TsF/TGF-β2可能导致肿瘤免疫监视功能受损。一些T细胞克隆可能逃避TGF-β的免疫抑制作用:对TGF-β表现出不同程度敏感性的卵清蛋白特异性T辅助细胞系中,含有已失去TGF-β受体的克隆。

相似文献

1
Expression of TGF-beta 2 in human glioblastoma: a role in resistance to immune rejection?转化生长因子-β2在人胶质母细胞瘤中的表达:在抵抗免疫排斥中起作用?
Ciba Found Symp. 1991;157:232-8; discussion 238-41. doi: 10.1002/9780470514061.ch15.
2
Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.胶质母细胞瘤中的免疫抑制与转化生长因子-β。转化生长因子-β2的优先产生。
J Immunol. 1989 Nov 15;143(10):3222-9.
3
Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice.转化生长因子-β抑制病毒感染小鼠中细胞毒性T细胞的生成。
J Immunol. 1989 Nov 15;143(10):3230-4.
4
The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor.
Eur J Immunol. 1988 Apr;18(4):593-600. doi: 10.1002/eji.1830180416.
5
Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.
J Neurosurg. 1989 Aug;71(2):211-7. doi: 10.3171/jns.1989.71.2.0211.
6
The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells.胶质母细胞瘤衍生的T细胞抑制因子/转化生长因子β2可抑制淋巴因子激活的杀伤细胞(LAK细胞)的生成。
Int J Cancer. 1988 Oct 15;42(4):562-7. doi: 10.1002/ijc.2910420416.
7
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family.人胶质母细胞瘤衍生的T细胞抑制因子的互补DNA,转化生长因子-β基因家族的一个新成员。
EMBO J. 1987 Dec 1;6(12):3673-7. doi: 10.1002/j.1460-2075.1987.tb02700.x.
8
Transforming growth factor-beta (TGF-beta)-resistant helper T lymphocyte clones show a concomitant loss of all three types of TGF-beta receptors.对转化生长因子-β(TGF-β)具有抗性的辅助性T淋巴细胞克隆显示出三种类型的TGF-β受体同时缺失。
J Immunol. 1991 May 1;146(9):3063-7.
9
Secretion of transforming growth factor-beta 1 and -beta 2 by malignant glioma cells.
Neurol Med Chir (Tokyo). 1995 Jul;35(7):423-30. doi: 10.2176/nmc.35.423.
10
Transforming growth factor-beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice.正常、裸鼠和严重联合免疫缺陷(SCID)小鼠病毒感染期间转化生长因子-β表达及自然杀伤细胞反应
J Immunol. 1993 Nov 1;151(9):4874-90.

引用本文的文献

1
Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated γδ T lymphocytes.胶质母细胞瘤细胞增强磷酸抗原刺激的 γδ T 淋巴细胞中 Th1 样表型的诱导。
J Neurooncol. 2021 Jul;153(3):403-415. doi: 10.1007/s11060-021-03787-7. Epub 2021 Jun 14.
2
Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies.解析胶质母细胞瘤微环境:开辟全新治疗策略的第一步。
Genes (Basel). 2021 Mar 20;12(3):445. doi: 10.3390/genes12030445.
3
Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors.
增强 T 细胞疗法治疗中枢神经系统肿瘤疗效的策略。
Front Immunol. 2020 Nov 12;11:599253. doi: 10.3389/fimmu.2020.599253. eCollection 2020.
4
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.胶质母细胞瘤中的分子异质性和免疫抑制微环境。
Front Immunol. 2020 Jul 17;11:1402. doi: 10.3389/fimmu.2020.01402. eCollection 2020.
5
Repurposing existing agents as adjunct therapies for glioblastoma.将现有药物重新用作胶质母细胞瘤的辅助治疗手段。
Neurooncol Pract. 2016 Sep;3(3):154-163. doi: 10.1093/nop/npv041. Epub 2015 Sep 30.
6
Current state and future prospects of immunotherapy for glioma.胶质母细胞瘤的免疫治疗现状及展望。
Immunotherapy. 2018 Feb 1;10(4):317-339. doi: 10.2217/imt-2017-0122.
7
Immune Evasion Strategies of Glioblastoma.胶质母细胞瘤的免疫逃逸策略
Front Surg. 2016 Mar 2;3:11. doi: 10.3389/fsurg.2016.00011. eCollection 2016.
8
GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway.胶质母细胞瘤衍生的神经节苷脂通过激活涉及外源性和内源性途径的半胱天冬酶级联反应诱导T细胞凋亡。
PLoS One. 2015 Jul 30;10(7):e0134425. doi: 10.1371/journal.pone.0134425. eCollection 2015.
9
VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFβR signaling-dependent manner.血管内皮生长因子受体(VEGFR)抑制剂以转化生长因子β受体(TGFβR)信号依赖的方式上调表达VEGF受体的胶质母细胞瘤中的CXCR4。
Cancer Lett. 2015 Apr 28;360(1):60-7. doi: 10.1016/j.canlet.2015.02.005. Epub 2015 Feb 9.
10
Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.细胞因子:放疗后胶质瘤细胞与肿瘤微环境之间平衡的转变
J Cancer Res Clin Oncol. 2015 Apr;141(4):575-89. doi: 10.1007/s00432-014-1772-6. Epub 2014 Jul 9.